| 國立成功大學 |
2007-08 |
Cost-effectiveness of highly active Antiretroviral therapy for HIV infection in Taiwan
|
Fang, Chi-Tai; Chang, Yu-Yin; Hsu, Hsu-Mei; Twu, Shiing-Jer; Chen, Kow-Tong; Chen, Mao-Yuan; Huang, Loreen Y. L.; Hwang, Ling-Shiang; Wang, Jung-Der |
| 國立臺灣大學 |
2007 |
Cost-effectiveness of Highly Active Antiretroviral Therapy for HIV Infection in Taiwan
|
Fang, Chi-Tai; Chang, Yu-Yin; Hsu, Hsu-Mei; Twu, Shiing-Jer; Chen, Kow-Tong; Chen, Mao-Yuan; Huang, Loreen Y.L.; Hwang, Jing-Shiang; Wang, Jung-Der |
| 國立臺灣大學 |
2007-08 |
Cost-effectiveness of highly active antiretroviral therapy for HIV infection in Taiwan
|
方啟泰; 張郁瑩; 許須美; 涂醒哲; 陳國東; 陳茂源; 黃鈺玲; 黃景祥; 王榮德 |
| 臺大學術典藏 |
2018-09-10T06:16:05Z |
Cost-effectiveness of highly active antiretroviral therapy for HIV infection in Taiwan
|
方啟泰;張郁瑩;許須美;涂醒哲;陳國東;陳茂源;黃鈺玲;黃景祥;王榮德; Fang, C.-T. and Chang, Y.-Y. and Hsu, H.-M. and Twu, S.-J. and Chen, K.-T. and Chen, M.-Y. and Huang, L.Y.L. and Hwang, J.-S. and Wang, J.-D.; CHI-TAI FANG |
| 臺大學術典藏 |
2021-04-20T03:46:20Z |
Cost-effectiveness of highly active antiretroviral therapy for HIV infection in Taiwan
|
Chi-Tai Fang;Chang Y.-Y.;Hsu H.-M.;Twu S.-J.;Chen K.-T.;Chen M.-Y.;Huang L.Y.L.;Hwang J.-S.;Wang J.-D.; CHI-TAI FANG; Chang Y.-Y.; Hsu H.-M.; Twu S.-J.; Chen K.-T.; Chen M.-Y.; Huang L.Y.L.; Hwang J.-S.; Wang J.-D. |
| 國立臺灣大學 |
2010-01 |
Cost-effectiveness of human papillomavirus vaccination for prevention of cervical cancer in Taiwan
|
劉邦祥; 胡賦強; 李秉穎; 周松男; 王榮德; LIU, PANG-HSIANG; HU, FU-CHANG; LEE, PING-ING; CHOW, SONG-NAN; WANG, JUNG-DER |
| 臺大學術典藏 |
2010 |
Cost-effectiveness of human papillomavirus vaccination for prevention of cervical cancer in Taiwan
|
Liu P.-H.;Hu F.-C.;Ping-Ing Lee;Chow S.-N.;Huang C.-W.;Wang J.-D.; Liu P.-H.; Hu F.-C.; PING-ING LEE; Chow S.-N.; Huang C.-W.; Wang J.-D. |
| 國立臺灣大學 |
2009 |
Cost-Effectiveness of Human Papillomavirus Vaccine for Prevention of Cervical Cancer in Taiwan
|
劉邦祥; 王榮德; LIU, PANG-HSIANG; WANG, JUNG-DER |
| 臺大學術典藏 |
2020-01-14T03:33:10Z |
Cost-effectiveness of influenza control measures: A dynamic transmission model-based analysis
|
CHUNG-MIN LIAO; Liao C.-M.; Chen S.-C.; Chen S.-C.;Liao C.-M. |
| 中山醫學大學 |
2013-12 |
Cost-effectiveness of influenza control measures: a dynamic transmission model-based analysis.
|
Chen SC;Liao CM. |
| 嘉南藥理大學 |
2023 |
Cost-effectiveness of Intensive vs Standard Blood Pressure Control Among Older Patients With Hypertension
|
Zhang, Zhen-Yu; Melgarejo, Jesus; Wei, Dongmei; Hu, Angie; Sun, Li; Yang, Chun-Ting; Liao, Chia-Te; Toh, Han Siong |
| 國立成功大學 |
2023 |
Cost-effectiveness of Intensive vs Standard Blood Pressure Control Among Older Patients With Hypertension
|
Liao, C.-T.;Toh, H.S.;Sun, L.;Yang, C.-T.;Hu, A.;Wei, D.;Melgarejo, J.;Zhang, Zhang Z.-Y. |
| 國立成功大學 |
2021 |
Cost-Effectiveness of Juluca (dolutegravir/rilpivirine) for Human Immunodeficiency Virus (HIV-1) Infection Treatment in Virologically Suppressed Adults in Taiwan
|
Anderson, S.-J.;Hsu, C.-Y.;Ou, H.-T.;Ko, N.-Y.;Yang, C.-T.;Lopes, S. |
| 國立成功大學 |
2020-05 |
Cost-effectiveness of long-acting insulin analogues vs intermediate/long-acting human insulin for type 1 diabetes: A population-based cohort followed over 10 years
|
Lee;Tsung-Ying;Kuo;Shihchen;Yang;Chen-Yi;Ou;Huang-Tz |
| 國立成功大學 |
2021 |
Cost-Effectiveness of Nivolumab Plus Ipilimumab With and Without Chemotherapy for Advanced Non-Small Cell Lung Cancer
|
Yang, S.-C.;Kunst, N.;Gross, C.P.;Wang, J.-D.;Su, W.-C.;Wang, S.-Y. |
| 臺大學術典藏 |
2018-09-10T15:26:31Z |
Cost-effectiveness of non-surgical peri-implantitis treatments
|
Listl, S. ; Fr\\Uhauf, N. ; Dannewitz, B. ; Weis, C. ; Tu, Y.-K. ; Chang, H.-J. ; Faggion, C.M.; YU-KANG TU |
| 臺大學術典藏 |
2022-05-10T08:10:18Z |
Cost-effectiveness of non-surgical peri-implantitis treatments
|
Listl S.; Fr?hauf N.; Dannewitz B.; Weis C.; YU-KANG TU; Chang H.-J.; Faggion C.M. |
| 國立成功大學 |
2023-01-12 |
Cost-effectiveness of Novel Macrophage-Regulating Treatment for Wound Healing in Patients With Diabetic Foot Ulcers From the Taiwan Health Care Sector Perspective
|
Su;Hsuan-Yu;Yang;Chen-Yi;Ou;Huang-Tz;Chen;Shyi-Gen;Chen;Jui-Ching;Ho;Hui-Ju;Kuo;Shihchen |
| 國立成功大學 |
2007-09 |
Cost-effectiveness of peginterferon alfa-2a compared to lamivudine treatment in patients with hepatitis B e antigen positive chronic hepatitis B in Taiwan
|
Sean D Sullivan; David L Veenstra; Chen, Pei-Jer; Chang, Ting-Tsung; Chuang, Wan-Long; Tsai, Chiaming; Patel, Kavita |
| 國立臺灣大學 |
2007 |
Cost-Effectiveness of Peginterferon Alfa-2a Compared to Lamivudine Treatment in Patients with Hepatitis B E Antigen Positive Chronic Hepatitis B in Taiwan
|
陳培哲; 張定宗; 莊萬龍; CHEN, PEI-JER; CHANG, TING-TSUNG; CHUANG, WAN-LONG |
| 臺大學術典藏 |
2021-07-03T03:35:09Z |
Cost-effectiveness of peginterferon alfa-2a compared to lamivudine treatment in patients with hepatitis B e antigen positive chronic hepatitis B in Taiwan
|
Sullivan S.D.; Veenstra D.L.; PEI-JER CHEN; Chang T.-T.; Chuang W.-L.; Tsai C.; Patel K. |
| 國立臺灣大學 |
2007-09 |
Cost-effectiveness of peginterferon alpha-2a compared to lamivudine treatment in patients with hepatitis B e antigen positive chronic hepatitis B in Taiwan.
|
Sullivan, SD; Veenstra, DL; Chen, PJ; Chang, TT; Chuang, WL; Tsai, C; Patel, K. |
| 國立成功大學 |
2021-03-10 |
Cost-effectiveness of percutaneous coronary intervention versus medical therapy in patients with acute myocardial infarction: real-world and lifetime-horizon data from Taiwan
|
Liao;Chia-Te;Hsieh;Tung-Han;Shih;Chia-Yin;Liu;Ping-Yen;Wang;Jung-Der |
| 臺大學術典藏 |
2022-08-19T00:20:36Z |
Cost-effectiveness of preventing hepatitis B virus reactivation in patients with lymphoma and resolved HBV infection
|
Cheng A.-L.; CHIUN HSU; Taiwan Cooperative Oncology Group; Chen P.-J.; Tsui C.-W.; Wu H.-Y.; Hsu Y.-T.; Chuang M.-H.; Hsiung C.A.; Liu T.-W.; Yang H.-C.; Hsiao C.-F.; Tsou H.-H. |
| 國家衛生研究院 |
2019-06-21 |
Cost-effectiveness of preventing hepatitis B virus reactivation in patients with lymphoma and resolved HBV infection
|
Tsou, HH;Yang, HC;Hsiao, CF;Hsiung, CA;Liu, TW;Chuang, MH;Wu, HY;Hsu, YT;Tsui, CW;Chen, PJ;Cheng, AL;Hsu, C; the Taiwan Cooperative Oncology Group |
| 臺大學術典藏 |
2019-08-29T07:31:06Z |
Cost-effectiveness of preventing hepatitis B virus reactivation in patients with lymphoma and resolved HBV infection
|
Tsou, Hsiao-Hui;Hung-Chih Yang;Hsiao, Chin-Fu;Hsiung, Chao A;Liu, Tsang-Wu;Chuang, Mei-Hsing;Wu, Hsiao-Yu;Hsu, Ya-Ting;Tsui, Chiung-Wen;Pei-Jer Chen;Ann-Lii Cheng;Hsu, Chiun; Tsou, Hsiao-Hui; HUNG-CHIH YANG; Hsiao, Chin-Fu; Hsiung, Chao A; Liu, Tsang-Wu; Chuang, Mei-Hsing; Wu, Hsiao-Yu; Hsu, Ya-Ting; Tsui, Chiung-Wen; PEI-JER CHEN; ANN-LII CHENG; Hsu, Chiun |
| 臺大學術典藏 |
2020-04-10T12:50:59Z |
Cost-effectiveness of preventing hepatitis B virus reactivation in patients with lymphoma and resolved HBV infection
|
Tsou H.-H.;Yang H.-C.;Hsiao C.-F.;Hsiung C.A.;Liu T.-W.;Chuang M.-H.;Wu H.-Y.;Hsu Y.-T.;Tsui C.-W.;Chen P.-J.;Cheng A.-L.;Chiun Hsu;Taiwan Cooperative Oncology Group; Tsou H.-H.; Yang H.-C.; Hsiao C.-F.; Hsiung C.A.; Liu T.-W.; Chuang M.-H.; Wu H.-Y.; Hsu Y.-T.; Tsui C.-W.; Chen P.-J.; Cheng A.-L.; Chiun Hsu; Taiwan Cooperative Oncology Group |
| 臺大學術典藏 |
2021-07-12T02:44:25Z |
Cost-effectiveness of preventing hepatitis B virus reactivation in patients with lymphoma and resolved HBV infection
|
Tsou H.-H; | HUNG-CHIH YANG; | Hsiao C.-F; | Hsiung C.A; | Liu T.-W; | Chuang M.-H; | Wu H.-Y; | Hsu Y.-T; | Tsui C.-W; | Chen P.-J; | Cheng A.-L; | Hsu C; | Taiwan Cooperative Oncology Group |
| 臺大學術典藏 |
2021-07-03T03:33:29Z |
Cost-effectiveness of preventing hepatitis B virus reactivation in patients with lymphoma and resolved HBV infection
|
Tsou H.-H.; Yang H.-C.; Hsiao C.-F.; Hsiung C.A.; Liu T.-W.; Chuang M.-H.; Wu H.-Y.; Hsu Y.-T.; Tsui C.-W.; PEI-JER CHEN; Cheng A.-L.; Hsu C.; Taiwan Cooperative Oncology Group |
| 臺大學術典藏 |
2021-08-31T06:29:20Z |
Cost-effectiveness of preventing hepatitis B virus reactivation in patients with lymphoma and resolved HBV infection
|
Tsou H.-H.; Yang H.-C.; Hsiao C.-F.; Hsiung C.A.; Liu T.-W.; Chuang M.-H.; Wu H.-Y.; Hsu Y.-T.; Tsui C.-W.; Chen P.-J.; ANN-LII CHENG; Hsu C.; Taiwan Cooperative Oncology Group |
| 臺北醫學大學 |
2009 |
Cost-Effectiveness of Prophylactic Human Papillomavirus (HPV) Vaccine for Prevention of Cervical Cancer in A Country with High Prevalence of HPV Infection
|
Pang-Hsiang Liu; Fu-Chang Hu; Chao-Wan Huang;Jung-Der Wang |
| 國家衛生研究院 |
2013-11 |
Cost-effectiveness of rotavirus vaccination programs in Taiwan
|
Chang, WC;Yen, C;Chi, CL;Wu, FT;Huang, YC;Lin, JS;Huang, FC;Tate, JE;Wu, HS;Hsiung, CA |
| 臺北醫學大學 |
2013 |
Cost-effectiveness of rotavirus vaccination programs in Taiwan
|
WC, Chang;Catherine, Yen;CL, Chia;FT, Wu;YC, Huang;JS, Line;FC, Huang;Jacqueline, Tate;HS, Wu;CA, Hsiung |
| 國立臺灣大學 |
2011 |
Cost-Effectiveness of Screening in an Outbreak
|
王怡人; 陳保中; 吳俞哖; 林水龍; WANG, I-JEN; CHEN, PAU-CHUNG; WU, YU-NIAN; LIN, SHOEI-LOONG |
| 臺大學術典藏 |
2018-09-10T08:49:02Z |
Cost-effectiveness of Screening in an Outbreak
|
王怡人;陳保中;吳俞哖;林水龍; Wang, I. J. and Huang, Y. C. and Chen, P. C. and Wu, Y. N. and Lin, S. L.; WANG, I-JEN;CHEN, PAU-CHUNG;WU, YU-NIAN;LIN, SHOEI-LOONG; Pau-Chung CHEN; WANG, I-JEN; CHEN, PAU-CHUNG; WU, YU-NIAN; LIN, SHOEI-LOONG; 林水龍 |
| 亞洲大學 |
2009 |
Cost-Effectiveness of Screening Syphilis among Pregnant Women in Mongolia
|
Enkhzaya chuluunbaatar |
| 國立成功大學 |
2022 |
Cost-effectiveness of sodium-glucose cotransporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors among patients with type 2 diabetes with and without established cardiovascular diseases: A model-based simulation analysis using 10-year real-world d
|
Peng, Z.-Y.;Yang, C.-T.;Ou, H.-T.;Kuo, S. |
| 國立成功大學 |
2022-07 |
Cost-effectiveness of sodium-glucose cotransporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors among patients with type 2 diabetes with and without established cardiovascular diseases: A model-based simulation analysis using 10-year real-world d
|
Peng;Zi-Yang;Yang;Chun-Ting;Ou;Huang-Tz;Kuo;Shihchen |
| 嘉南藥理大學 |
2016-05 |
Cost-effectiveness of sorafenib versus SBRT for unresectable advanced hepatocellular carcinoma
|
Leung, Henry W. C.; Liu, Chung-Feng; Chan, Agnes L. F. |
| 臺大學術典藏 |
2020-12-17T02:40:26Z |
Cost-effectiveness of statin therapy for secondary prevention among patients with coronary artery disease and baseline LDL-C 70-100 mg/dL in Taiwan
|
Tu S.-T.; Yeh S.-J.; Chen C.-I.; Lu K.-C.; Wu C.-C.; Shau W.-Y.; Inocencio T.J.; Wen Y.-C.; Yeh H.-I.; FANG-JU LIN; Shyu K.-G.; Hsieh I.-C.; Huey-Herng Sheu W. |
| 臺大學術典藏 |
2020-10-12T10:15:04Z |
Cost-effectiveness of statin therapy for secondary prevention among patients with coronary artery disease and baseline LDL-C 70-100 mg/dL in Taiwan
|
Inocencio, Timothy J; Wen, Yao-Chun; Yeh, Hung-I; Shau, Wen-Yi; Wu, Chia-Chao; Lu, Kuo-Cheng; Chen, Chin-I; Yeh, Shoou-Jeng; Tu, Shih-Te; Huey-Herng Sheu, Wayne; Hsieh, I-Chang; Shyu, Kou-Gi; Lin, Fang-Ju |
| 臺大學術典藏 |
2020-12-17T02:19:45Z |
Cost-effectiveness of statin therapy for secondary prevention among patients with coronary artery disease and baseline LDL-C 70–100 mg/dL in Taiwan
|
FANG-JU LIN; Shyu K.-G.; Hsieh I.-C.; Huey-Herng Sheu W.; Tu S.-T.; Yeh S.-J.; Chen C.-I.; Lu K.-C.; Wu C.-C.; Shau W.-Y.; Inocencio T.J.; Wen Y.-C.; Yeh H.-I. |
| 臺大學術典藏 |
2020 |
Cost-effectiveness of statin therapy for secondary prevention among patients with coronary artery disease and baseline LDL-C 70–100 mg/dL in Taiwan
|
FANG-JU LIN; Shyu K.-G.; Hsieh I.-C.; Huey-Herng Sheu W.; Tu S.-T.; Yeh S.-J.; Chen C.-I.; Lu K.-C.; Wu C.-C.; Shau W.-Y.; Inocencio T.J.; Wen Y.-C.; Yeh H.-I. |
| 國家衛生研究院 |
2022-08-11 |
Cost-effectiveness of the add-on exenatide to conventional treatment in patients with Parkinson’s disease when considering the coexisting effects of diabetes mellitus
|
Chen, HC;Wang, CY;Chen, HH;Liou, HH |
| 臺大學術典藏 |
2018-09-10T18:05:59Z |
Cost-effectiveness of the pharmacist-assisted warfarin monitoring program at a Medical Center in Taiwan
|
Jen-Yu Chang;Chi-Chuan Wang;Hao-Cheng Kang;Li-Jiuan Shen;Chih-Fen Huang; CHI-CHUAN WANG; CHIH-FEN HUANG |
| 臺大學術典藏 |
2020-12-24T03:00:38Z |
Cost-effectiveness of the pharmacist-assisted warfarin monitoring program at a Medical Center in Taiwan
|
Chang J.-Y.;Wang C.-C.;Kang H.-C.;Li-Jiuan Shen;Huang C.-F.; Chang J.-Y.; Wang C.-C.; Kang H.-C.; LI-JIUAN SHEN; Huang C.-F. |
| 臺大學術典藏 |
2018-09-10T04:45:40Z |
Cost-effectiveness of treatment strategies for osteoarthritis of the knee in Taiwan
|
Yen, Z.-S. and Lai, M.-S. and Wang, C.-T. and Chen, L.-S. and Chen, S.-C. and Chen, W.-J. and Hou, S.-M.; ZUI-SHEN YEN |
| 臺大學術典藏 |
2018-09-10T04:57:58Z |
Cost-effectiveness of treatment strategies for osteoarthritis of the knee in Taiwan
|
Yen, Z.-S.;Lai, M.-S.;Wang, C.-T.;Chen, L.-S.;Chen, S.-C.;Chen, W.-J.;Hou, S.-M.; SHYR-CHYR CHEN |
| 臺大學術典藏 |
2019-09-21T08:10:04Z |
Cost-effectiveness of treatment strategies for osteoarthritis of the knee in Taiwan
|
Zui-Shen Yen;Lai, Mei-Shu;Chen-Ti Wang;Chen, Li-Shu;Shyr-Chyr Chen;Wen-Jone Chen;Hou, Sheng-Mou; ZUI-SHEN YEN; Lai, Mei-Shu; CHEN-TI WANG; Chen, Li-Shu; SHYR-CHYR CHEN; WEN-JONE CHEN; Hou, Sheng-Mou |
| 臺大學術典藏 |
2020-02-27T07:43:28Z |
Cost-effectiveness of treatment strategies for osteoarthritis of the knee in Taiwan
|
Hou S.-M.;WEN-JONE CHEN;Chen S.-C.;Chen L.-S.;Wang C.-T.;Lai M.-S.;Yen Z.-S.; Yen Z.-S.; Lai M.-S.; Wang C.-T.; Chen L.-S.; Chen S.-C.; WEN-JONE CHEN; Hou S.-M. |
